Congress
$1,001–$15,000
Traded Feb 25, 2025 · disclosed 30 days later
2 different filers disclosed MRNA within 90 days.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Mar 3, 2025 · Filed Mar 4, 2025
A Moderna director paid $1M out of pocket for Moderna shares. 1 other person at Moderna bought some too, in the same month. Shares held went up 11% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$1,004,251
Shares × reported transaction price
$1M+
+11.3%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
17 days after results of Feb 14, 2025, 59 days before results of May 1, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Aug 9, 2024 in the U.S. District Court, D. Massachusetts. A filing is an allegation, not a finding.
Wentz v. Moderna, Inc., docket 1:24-cv-12058, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −0.6% | −4.2% | +3.6% |
| 30 days | −28.7% | −13.3% | −15.3% |
| 90 days | −21.0% | +2.2% | −23.3% |
| 180 days | −31.3% | +9.8% | −41.1% |
| 365 days | +52.9% | +16.9% | +36.0% |
Past results only. Not a forecast.
Congress
Traded Feb 25, 2025 · disclosed 30 days later
2 different filers disclosed MRNA within 90 days.
Insider buying
Traded Mar 3, 2025 · filed 1 day later
The CEO of Moderna paid $3.19M out of pocket for Moderna shares. 1 other person at Moderna bought some too, in the same month.
Insider buying
Traded Mar 3, 2025 · filed 1 day later
The CEO of Moderna paid $1.81M out of pocket for Moderna shares. 1 other person at Moderna bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.